Collaboration Details

Print  Close


Title of Collaborative Activity:

HHS Behavioral Health Coordinating Council (BHCC) Overdose Prevention Subcommittee

Description of Collaborative Activity:

The National Institutes of Health (National Institute on Drug Abuse; NIDA) Serves as Co-Chair with the Food and Drug Administration (FDA) on this inter-agency subcommittee addressing drug overdose. NIDA participates on its constituent working groups whose topics include: drafting and implementation of the HHS Overdose Prevention Strategy; expanding access to contingency management; addressing pharmacy availability of buprenorphine; determining the public health impact of kratom scheduling; and improving clinician education on controlled substance prescribing.

Type of Collaborative Activity:

Committee, Advisory Group, or Work Group

Year the Collaborative Activity Originated:

2009

NIH Participating Institutes/Centers/Office of the Director:

NIDA, OD/OSP

HHS Agency Collaborators on this Activity:

AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA, OASH, ASPE